A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia
NCT01407289 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2013-02-05
Summary
The purpose of the study is to compare the efficacy of enhanced published best practice paper-based insulin titration protocol for glycaemic control in hospitalised patients with type 2 diabetes for the length of hospital stay.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Insulin Aspart, Insulin Glargine
The Intervention is a paper based protocol, which provides suggestions for new insulin doses (basal-bolus regime).
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Thomas Pieber, MD · Division of Endocrinology and Metabolism, Department of Internal Medicine Medical University of Graz
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- Austria
Study Locations
More Related Trials
-
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
NCT00469092 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
NCT01773798 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
NCT00267683 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
NCT02467920 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids
NCT01293396 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics
NCT01002768 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
NCT00670722 ·Status: COMPLETED
-
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
NCT01467323 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
NCT00184626 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus
NCT02933853 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
NCT01455142 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
NCT00177398 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
NCT00824668 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
NCT00312104 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glulisine in Diabetes Mellitus, Type 2
NCT00174668 ·Status: COMPLETED ·Phase: PHASE3
-
Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
NCT01121835 ·Status: COMPLETED ·Phase: PHASE4
-
Risk of Hypoglycemia in Type 2 Diabetes
NCT00734669 ·Status: COMPLETED
-
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
NCT06982846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
NCT00969592 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
NCT00283049 ·Status: TERMINATED ·Phase: PHASE4
-
Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes
NCT01526980 ·Status: COMPLETED ·Phase: PHASE2
-
Initiation of Insulin Aspart in Type 2 Diabetes
NCT00572806 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy
NCT02144441 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
NCT00434954 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
NCT02131246 ·Status: COMPLETED ·Phase: PHASE1